Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
ADC Therapeutics SA Common Shares
(NY:
ADCT
)
3.680
-0.150 (-3.92%)
Official Closing Price
Updated: 4:10 PM EDT, May 4, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about ADC Therapeutics SA Common Shares
< Previous
1
2
3
4
Next >
ADCT Q1 2026 Earnings Call Transcript
↗
Today 16:23 EDT
ADCT Q1 2026 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
ADC Therapeutics SA (NYSE:ADCT) Beats Q1 Estimates, But Market Reaction Remains Subdued
↗
Today 8:20 EDT
Via
Chartmill
ADC Therapeutics SA (NYSE:ADCT) Surges on Q4 2025 Earnings Beat and Pipeline Update
↗
March 10, 2026
Via
Chartmill
Topics
Earnings
These stocks are moving in today's session
↗
December 03, 2025
Looking for insights into the US markets in the middle of the day on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via
Chartmill
Earnings Scheduled For November 10, 2025
↗
November 10, 2025
Via
Benzinga
Earnings Preview For ADC Therapeutics
↗
November 07, 2025
Via
Benzinga
Preview: ADC Therapeutics's Earnings
↗
August 11, 2025
Via
Benzinga
Preview: ADC Therapeutics's Earnings
↗
May 13, 2025
Via
Benzinga
Which stocks are gapping on Wednesday?
↗
December 03, 2025
The market is buzzing with gapping stocks on Wednesday. Let's uncover which stocks are experiencing notable gaps during today's session.
Via
Chartmill
ADC Therapeutics (ADCT) Earnings Call Transcript
↗
November 10, 2025
ADC Therapeutics (ADCT) Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
October 02, 2025
Via
Benzinga
Top 5 Biotech Stocks With Strong Momentum
↗
August 28, 2025
Top 5 biotech stocks jumping into the top 10% momentum this week—ADCT, ARQT, CLLS, ENTO, HOTH—amid rapid sector rallies.
Via
Benzinga
A Preview Of ADC Therapeutics's Earnings
↗
March 26, 2025
Via
Benzinga
ADC Therapeutics's Earnings: A Preview
↗
November 06, 2024
Via
Benzinga
A Preview Of ADC Therapeutics's Earnings
↗
March 12, 2024
Via
Benzinga
Earnings Scheduled For August 12, 2025
↗
August 12, 2025
Via
Benzinga
Which stocks are moving on Wednesday?
↗
May 14, 2025
Let's have a look at what is happening on the US markets one hour before the close of the markets on Wednesday. Below you can find the top gainers and losers in today's session.
Via
Chartmill
Top movers analysis in the middle of the day on 2025-05-14: top gainers and losers in today's session.
↗
May 14, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
ADC Therapeutics Faces Competitive Oncology Market But Analyst Sees 100% Upside - Here's Why
↗
November 08, 2024
Stephens initiates coverage on ADC Therapeutics (ADCT), highlighting Zynlonta's potential in second-line DLBCL and a promising oncology pipeline. Overweight rating, $6 price target.
Via
Benzinga
ADCT Stock Earnings: ADC Therapeutics Beats EPS, Misses Revenue for Q2 2024
↗
August 06, 2024
ADCT stock results show that ADC Therapeutics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Earnings Scheduled For May 14, 2025
↗
May 14, 2025
Via
Benzinga
Earnings Scheduled For March 27, 2025
↗
March 27, 2025
Via
Benzinga
7 Growth Stocks to Buy for Under $5 for Massive Gains
↗
July 11, 2024
Although growth stocks under $5 are inherently risky and unpredictable, their very nature also facilitates robust upside potential.
Via
InvestorPlace
Intapp, ServiceNow And Other Big Stocks Moving Lower In Monday's Pre-Market Session
↗
July 08, 2024
Via
Benzinga
Stocks to Buy: 3 Biotech Bargains Delivering Breakthroughs on a Budget
↗
June 13, 2024
Since wealth without health is utterly meaningless, investors may have some confidence with these biotech stocks to buy.
Via
InvestorPlace
ADCT Stock Earnings: ADC Therapeutics Beats EPS, Misses Revenue for Q1 2024
↗
May 06, 2024
ADCT stock results show that ADC Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
BioNTech Reports Downbeat Earnings, Joins Medical Properties Trust And Other Big Stocks Moving Lower In Monday's Pre-Market Session
↗
May 06, 2024
Via
Benzinga
Medifast Reports Mixed Results, Joins Coursera, Chegg And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
↗
April 30, 2024
Via
Benzinga
Dollar Tree Reports Weak Earnings, Joins Tesla, Arcos Dorados And Other Big Stocks Moving Lower On Wednesday
↗
March 13, 2024
U.S. stocks were mixed, with the Dow Jones index surging more than 100 points on Wednesday.
Via
Benzinga
Topics
Stocks
Earnings Scheduled For March 13, 2024
↗
March 13, 2024
Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million.
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.